Literature DB >> 27905021

Netherton Syndrome: A Genotype-Phenotype Review.

Constantina A Sarri1, Angeliki Roussaki-Schulze2, Yiannis Vasilopoulos1, Efterpi Zafiriou2, Aikaterini Patsatsi3, Costas Stamatis1, Polyxeni Gidarokosta2, Dimitrios Sotiriadis3, Theologia Sarafidou1, Zissis Mamuris4.   

Abstract

Netherton syndrome (OMIM #256500) is a rare but severe autosomal recessive form of ichthyosis that affects the skin, hair, and immune system. The identification of SPINK5, which encodes for the serine protease inhibitor LEKTI, as the gene responsible for Netherton syndrome, enabled the search for causative mutations in Netherton syndrome patients and families. However, information regarding these mutations and their association with the pathological Netherton syndrome phenotype is scarce. Herein, we provide an up-to-date overview of 80 different mutations in exonic as well as intronic regions that have been currently identified in 172 homozygous or compound heterozygous patients from 144 families. Genotypes with mutations located more upstream in LEKTI correlate with more severe phenotypes compared with similar mutations located towards the 3' region. Furthermore, splicing mutations and post-transcriptional mechanism of nonsense-mediated mRNA decay affect LEKTI expression in variable ways. Genotype-phenotype correlations form the basis of prenatal diagnosis in families with a history of Netherton syndrome and when consanguinity is implied.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27905021     DOI: 10.1007/s40291-016-0243-y

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  77 in total

1.  Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping.

Authors:  S Chavanas; C Garner; C Bodemer; M Ali; D H Teillac; J Wilkinson; J L Bonafé; M Paradisi; D P Kelsell; S i Ansai; Y Mitsuhashi; M Larrègue; I M Leigh; J I Harper; A Taïeb; Y d Prost; L R Cardon; A Hovnanian
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

2.  Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.

Authors:  Arumugam Jayakumar; Ya'an Kang; Kenji Mitsudo; Ying Henderson; Mitchell J Frederick; Mary Wang; Adel K El-Naggar; Ute C Marx; Katrina Briggs; Gary L Clayman
Journal:  Protein Expr Purif       Date:  2004-05       Impact factor: 1.650

3.  Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.

Authors:  Nahoko Komatsu; Kiyofumi Saijoh; Norio Otsuki; Tadaaki Kishi; Iacovos P Micheal; Christina V Obiezu; Carla A Borgono; Kazuhiko Takehara; Arumugam Jayakumar; Hua Kang Wu; Gary L Clayman; Eleftherios P Diamandis
Journal:  Clin Chim Acta       Date:  2006-10-19       Impact factor: 3.786

4.  Netherton syndrome: report of identical twins presenting with severe atopic dermatitis.

Authors:  Gurkan Kilic; Nermin Guler; Ulker Ones; Zeynep Tamay; Pinar Guzel
Journal:  Eur J Pediatr       Date:  2006-05-03       Impact factor: 3.183

5.  Prenatal diagnosis of a lethal form of Netherton syndrome by SPINK5 mutation analysis.

Authors:  E Bitoun; C Bodemer; J Amiel; Y de Prost; C Stoll; P Calvas; A Hovnanian
Journal:  Prenat Diagn       Date:  2002-02       Impact factor: 3.050

6.  A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.

Authors:  Carla A Borgoño; Iacovos P Michael; Nahoko Komatsu; Arumugam Jayakumar; Ravi Kapadia; Gary L Clayman; Georgia Sotiropoulou; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

7.  Kallikrein gene expression in human pituitary tissues.

Authors:  J A Clements; A Mukhtar; K Verity; M Pullar; P McNeill; J Cummins; P J Fuller
Journal:  Clin Endocrinol (Oxf)       Date:  1996-02       Impact factor: 3.478

8.  LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.

Authors:  Emmanuelle Bitoun; Alessia Micheloni; Laurence Lamant; Chrystelle Bonnart; Alessandro Tartaglia-Polcini; Christian Cobbold; Talal Al Saati; Feliciana Mariotti; Juliette Mazereeuw-Hautier; Franck Boralevi; Daniel Hohl; John Harper; Christine Bodemer; Marina D'Alessio; Alain Hovnanian
Journal:  Hum Mol Genet       Date:  2003-07-29       Impact factor: 6.150

9.  Comèl-Netherton syndrome defined as primary immunodeficiency.

Authors:  Ellen D Renner; Dominik Hartl; Stacey Rylaarsdam; Marguerite L Young; Linda Monaco-Shawver; Gary Kleiner; M Louise Markert; E Richard Stiehm; Bernd H Belohradsky; Melissa P Upton; Troy R Torgerson; Jordan S Orange; Hans D Ochs
Journal:  J Allergy Clin Immunol       Date:  2009-08-14       Impact factor: 10.793

10.  SPINK5 gene mutation and decreased LEKTI activity in three Chinese patients with Netherton's syndrome.

Authors:  Y Zhao; Z H Ma; Y Yang; S X Yang; L S Wu; B L Ding; Z M Lin; A P Wang; D F Bu; P Tu
Journal:  Clin Exp Dermatol       Date:  2007-07-02       Impact factor: 3.470

View more
  14 in total

Review 1.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

2.  Acral peeling in Nagashima type palmo-plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion.

Authors:  Eran Cohen-Barak; Wassim Azzam; Jennifer L Koetsier; Nada Danial-Farran; Moran Barcan; Maysa Hriesh; Morad Khayat; Natalia Edison; Judith Krausz; Chen Gafni-Amsalem; Akiharu Kubo; Lisa M Godsel; Michael Ziv; Stavit Allon-Shalev
Journal:  Exp Dermatol       Date:  2021-08-17       Impact factor: 4.511

3.  A novel mutation in SPINK5 gene underlies a case of atypical Netherton syndrome.

Authors:  Yu Wang; Hanqing Song; Lingling Yu; Nan Wu; Xiaodong Zheng; Bo Liang; Peiguang Wang
Journal:  Front Genet       Date:  2022-09-09       Impact factor: 4.772

4.  Otitis media susceptibility and shifts in the head and neck microbiome due to SPINK5 variants.

Authors:  Daniel N Frank; Arnaud P J Giese; Lena Hafren; Tori C Bootpetch; Talitha Karisse L Yarza; Matthew J Steritz; Melquiadesa Pedro; Patrick John Labra; Kathleen A Daly; Ma Leah C Tantoco; Wasyl Szeremeta; Maria Rina T Reyes-Quintos; Niaz Ahankoob; Erasmo Gonzalo D V Llanes; Harold S Pine; Sairah Yousaf; Diana Ir; Elisabet Einarsdottir; Rhodieleen Anne R de la Cruz; Nanette R Lee; Rachelle Marie A Nonato; Charles E Robertson; Kimberly Mae C Ong; Jose Pedrito M Magno; Alessandra Nadine E Chiong; Ma Carmina Espiritu-Chiong; Maria Luz San Agustin; Teresa Luisa G Cruz; Generoso T Abes; Michael J Bamshad; Eva Maria Cutiongco-de la Paz; Juha Kere; Deborah A Nickerson; Karen L Mohlke; Saima Riazuddin; Abner Chan; Petri S Mattila; Suzanne M Leal; Allen F Ryan; Zubair M Ahmed; Tasnee Chonmaitree; Michele M Sale; Charlotte M Chiong; Regie Lyn P Santos-Cortez
Journal:  J Med Genet       Date:  2020-07-24       Impact factor: 6.318

Review 5.  Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.

Authors:  Jing Wu; Li Hong; Tong-Xin Chen
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-15       Impact factor: 4.919

6.  Genetic Signature of Acute Lymphoblastic Leukemia and Netherton Syndrome Co-incidence-First Report in the Literature.

Authors:  Szymon Skoczen; Konrad Stepien; Wojciech Mlynarski; Piotr Centkowski; Kinga Kwiecinska; Michal Korostynski; Marcin Piechota; Elzbieta Wyrobek; Angelina Moryl-Bujakowska; Wojciech Strojny; Magdalena Rej; Jerzy Kowalczyk; Walentyna Balwierz
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

7.  Clinical and genetic investigation of ichthyosis in familial and sporadic cases in south of Tunisia: genotype-phenotype correlation.

Authors:  Mariem Ennouri; Andreas D Zimmer; Emna Bahloul; Rim Chaabouni; Slaheddine Marrakchi; Hamida Turki; Faiza Fakhfakh; Noura Bougacha-Elleuch; Judith Fischer
Journal:  BMC Med Genomics       Date:  2022-01-05       Impact factor: 3.063

8.  NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.

Authors:  Francisco J Martínez-Morcillo; Joaquín Cantón-Sandoval; Francisco J Martínez-Navarro; Isabel Cabas; Idoya Martínez-Vicente; Joy Armistead; Julia Hatzold; Azucena López-Muñoz; Teresa Martínez-Menchón; Raúl Corbalán-Vélez; Jesús Lacal; Matthias Hammerschmidt; José C García-Borrón; Alfonsa García-Ayala; María L Cayuela; Ana B Pérez-Oliva; Diana García-Moreno; Victoriano Mulero
Journal:  PLoS Biol       Date:  2021-11-08       Impact factor: 8.029

9.  Infliximab therapy for Netherton syndrome: A case report.

Authors:  Ângela Roda; Maria Mendonça-Sanches; Ana Rita Travassos; Luís Soares-de-Almeida; Dieter Metze
Journal:  JAAD Case Rep       Date:  2017-11-06

10.  A New Splice-site Mutation of SPINK5 Gene in the Netherton Syndrome with Different Clinical Features: A Case Report.

Authors:  E Erden; A C Ceylan; S Emre
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.